Key facts
- This page summarizes Richard Glenn Hillyer's Form 3 filing for Health In Tech, Inc. (HIT).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2024, 21:00.
Richard Glenn Hillyer - 20 Dec 2024 Form 3 Insider Report for Health In Tech, Inc. (HIT)
- Reporting relationship
- Chief Growth Officer
- Issuer ticker
- HIT
- Reported as of
- 20 Dec 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ (Richard) Glenn Hillyer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Richard Glenn Hillyer filed Form 3 for Health In Tech, Inc. (HIT) on 20 Dec 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HIT
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 29,988
- Date
- 20 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
HIT
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,000
- Date
- 20 Dec 2024
- Ownership
- Direct
- Footnotes
- F2
HIT
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,175
- Date
- 20 Dec 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HIT
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Dec 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 15,000
- Exercise price
- $0.7100
- Footnotes
- F4
HIT
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Dec 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 77,325
- Exercise price
- $0.7100
- Footnotes
- F5
HIT
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Dec 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 34,797
- Exercise price
- $0.7100
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
Footnote F2
Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
Footnote F3
Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The Restricted Stock vest over three years, with one-third of the Restricted Stock vesting upon the closing of the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.
Footnote F4
Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest six months after the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.
Footnote F5
Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest over three years, with one-third of the options vesting upon the issuer's initial public offering and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date.
Footnote F6
Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest upon the closing of the issuer's initial public offering, subject to the reporting person's continued service with the issuer through such vesting date.